Hae Rang Kim, MD; Nang Kyeong Lee, MS; Youngsong Suh, MD; et al.
JAMA Ophthalmol. 2024;142(11):997-1004. doi:10.1001/jamaophthalmol.2024.3641
This Korean population-based cohort study evaluated the incidence rates and risks of depressive disorder in patients with retinitis pigmentosa.
-
Invited Commentary
Detection and Referral of Depression in Patients With Visual Impairment: A Call for Practical Training and Methods
Byron L. Lam, MD
JAMA Ophthalmol
-
Podcast:
Detection and Referral of Depression in Patients With Visual Impairment
Bo Qian, MS; Bin Sheng, PhD; Hao Chen, PhD; et al.
free access
JAMA Ophthalmol. 2024;142(11):1006-1015. doi:10.1001/jamaophthalmol.2024.3707
This diagnostic study details the results of an international competition to develop automated deep learning and artificial intelligence algorithms for classification and segmentation of myopic maculopathy and compares the algorithms’ performance with that of ophthalmologists.
-
Invited Commentary
Crowdsourcing for Artificial Intelligence Models in Ophthalmology
Shahin Hallaj, MD; Niloofar Radgoudarzi, BS; Sally L. Baxter, MD, MSc
JAMA Ophthalmol
Nikhita Yadlapalli, BS; Ruby Hollinger, MD, MSc; Shannan Berzack, BS; et al.
JAMA Ophthalmol. 2024;142(11):1018-1026. doi:10.1001/jamaophthalmol.2024.3569
This cross-sectional study examines whether federally qualified health centers in Florida offer eye care services, where the services are available, what services are being offered, and who provides them.
-
Invited Commentary
Federally Qualified Health Centers to Reduce Disparities in Ophthalmology
Roomasa Channa, MD; Fasika Woreta, MD, MPH
JAMA Ophthalmol
Mariano Cozzi, MSc; Alexander Ziegler, MD; Katrin Fasler, MD; et al.
open access
JAMA Ophthalmol. 2024;142(11):1028-1036. doi:10.1001/jamaophthalmol.2024.3828
This case series study evaluates the characteristics and outcomes of sterile intraocular inflammation after injection of faricimab to treat neovascular age-related macular degeneration or diabetic macular edema.
Todd. E. Scheetz, PHD; Mallory R. Tollefson, PHD; Ben R. Roos, BS; et al.
JAMA Ophthalmol. 2024;142(11):1037-1045. doi:10.1001/jamaophthalmol.2024.3829
This case-control study evaluates the presence of METTL23 variants in patients with autosomal dominant normal-tension glaucoma.
Joshua R. Ehrlich, MD, MPH; Zeb Burke-Conte, BS; John S. Wittenborn, BS; et al.
JAMA Ophthalmol. 2024;142(11):1046-1053. doi:10.1001/jamaophthalmol.2024.3884
This meta-analysis aimed to develop new multisource composite estimates of the prevalence of glaucoma and vision-affecting glaucoma in the US.
M. K. Quinn, PhD; Henry C. Lee, MD; Jochen Profit, MD; et al.
JAMA Ophthalmol. 2024;142(11):1055-1061. doi:10.1001/jamaophthalmol.2024.3909
This cohort study examines changes in the incidence of and racial disparities in retinopathy of prematurity (ROP) among preterm infants in California from 2012 to 2021 in the context of rising rates of ROP among premature infants in the US.
Gianni Virgili, MD; Riccardo Capocaccia, MSc; Laura Botta, MSc; et al.
JAMA Ophthalmol. 2024;142(11):1062-1070. doi:10.1001/jamaophthalmol.2024.4140
This cohort study estimates incidence and survival among children with retinoblastoma in 31 European countries as well as the occurrence of second primary tumors.
-
Invited Commentary
Incidence and Survival Rates in European Children With Retinoblastoma
Patricia Chévez-Barrios, MD; Guillermo L. Chantada, MD; Matthew W. Wilson, MD
JAMA Ophthalmol
Ayse Gungor, MSc; Raymond P. Najjar, PhD; Steffen Hamann, MD, PhD; et al.
free access
JAMA Ophthalmol. 2024;142(11):1073-1079. doi:10.1001/jamaophthalmol.2024.4269
This cohort study evaluates the use of a deep learning system to discriminate arteritic from nonarteritic anterior ischemic optic neuropathy on color fundus images.
-
Invited Commentary
Deep Learning to Improve Diagnosis Must Also Not Do Harm
Heather E. Moss, MD, PhD
JAMA Ophthalmol